Poly (I:C) decreases HIV-1 replication in PBMCs. by Christiane Rollenhage (762318)

LAMP1 decreased within MoDCs infected with <i>P. gingivalis</i> expressing Mfa1. by Ahmed R. El-Awady (697683)

Foxa1 up-regulates UCP1 and decreases MMP. by Marta Moya (188959)

IL-1β decreases RBP4 production. by Primoz Kotnik (382835)

PSD-95 decreased ASIC2a acid-evoked current. by Anne Marie S. Harding (546425)

Nesfatin-1 decreased excitability of GI-neurons in DVC. by Jing Dong (102657)

<i>B. bassiana</i> decreased longevity and impaired climbing. by Deepanshu N. D. Singh (20721878)

TGF-β1 decreases RECK expression in fibroblasts. by Jaime Gutiérrez (401710)

<i>Zip88E</i>^<i>Δ/Δ</i> larvae have decreased <i>MtnB</i>:<i>EYFP</i> expression. by Christopher D. Richards (4246669)

“…<p>A, B, D, E) <i>MtnB</i>:<i>EYFP</i> expression in third instar larval midguts from control and <i>Zip88E</i>^<i>Δ/Δ</i> homozygous larvae on basal medium (A and B) and after exposure to 2 mmol l^-1 ZnCl₂-supplemented medium (D, E). …”

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

The M77K mutation decreases the calcium-induced activation of Nox5. by Yusi Wang (592335)

Decreased TORC1 activates HPK-1 to extend longevity. by Ritika Das (4514968)

“…<p>(A-D) Decreased TORC1 induces neuronal expression of HPK-1. …”

RNA interference-mediated decrease in Ixofin3D results in decreased <i>B. burgdorferi</i> burden in the salivary glands and in murine skin. by Sukanya Narasimhan (73432)

Bone mass and formation are decreased in Akt1-/- mice. by Naohiro Kawamura (33999)

CD11b and TLR-5 expression are decreased on CF macrophage membrane. by Karin Simonin-Le Jeune (464354)

FRAT1 depletion decreases tumorigenicity in nude mice. by Geng Guo (403691)

Conceptual framework for Child Health and Nutrition Initiative (CHNRI) showing steps from health research investment to a decrease in burden of death, disease, or disability. by Joy E. Lawn (124331)

S1 Data - by Toru Hosokawa (364158)

“…The bicaudate ratio increased in 38/58 (65.5%) patients, Evans index increased in 35/58 (60.3%) patients, and brain volume by volumetry decreased in 46/58 (79.3%) patients from the first to the second measurement, with significant increases in the bicaudate ratio (<i>P</i> < 0.0001) and Evans index (<i>P</i> = 0.0005) and a significant decrease in the brain volume by volumetry (<i>P</i> < 0.0001). …”

Inhibition of NLRP3 inflammasomes decreased 5-FU-induced cell death. by Kaya Yoshida (658943)